Laurus Labs Limited
LAURUSLABS
Rangering i aksjer
#1744
Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited,... Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited, along with its subsidiaries, operates as a diversified global pharmaceutical company. It focuses on the research, manufacturing, and international distribution of a broad spectrum of medicines and active pharmaceutical ingredients (APIs). The company's API and advanced intermediate offerings cover key therapeutic domains such as anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C. Additionally, Laurus Labs develops and produces oral solid dosage forms targeting ARV, antidiabetic, cardiovascular, PPI, and central nervous system (CNS) conditions. Beyond its proprietary products, the firm extends its expertise through contract development and manufacturing services for other pharmaceutical enterprises. It also supplies specialized ingredients vital for nutraceutical, dietary supplement, and cosmeceutical applications. Furthermore, Laurus Labs is at the forefront of innovation, engineering novel enzymatic solutions for industrial biotechnology, and providing animal-origin-free recombinant proteins and enzymes for biopharmaceutical use, alongside offering a range of business support services within the pharmaceutical industry.
Aksjekurs
$22.80
Markedsverdi
$12.32B
Endring (1 dag)
0.36%
Endring (1 år)
122.99%
Land
IN
Handel Laurus Labs Limited (LAURUSLABS)
Kategori
Healthcare
Utbyttehistorikk for Laurus Labs Limited (LAURUSLABS)
Laurus Labs Limited (aksjesymbol: LAURUSLABS) har gitt totalt 14 utbyttebetalinger.
Summen av alle utbytter (justert for aksjesplitt): $8.80
Utbytteavkastning (TTM): 0.001
Summen av alle utbytter (justert for aksjesplitt): $8.80
Utbytteavkastning (TTM): 0.001
Utbyttebetalinger for Laurus Labs Limited (LAURUSLABS) fra 2019 til 2026
Årlige utbyttebetalinger
| År | Utbytte (justert for aksjesplitt) | Endre |
|---|---|---|
| 2026 (TTM) | $0.8 | -50.00% |
| 2025 | $1.60 | 100.00% |
| 2024 | $0.8 | -50.00% |
| 2023 | $1.60 | 33.33% |
| 2022 | $1.20 | -40.00% |
| 2021 | $2.00 | 53.85% |
| 2020 | $1.30 | 333.33% |
| 2019 | $0.3 | 0.00% |
Liste over alle utbyttebetalinger
| År | Utbytte | Endre |
|---|---|---|
| 2026 (TTM) | $0.8 | -50.00% |
| 2025 | $1.60 | 100.00% |
| 2024 | $0.8 | -50.00% |
| 2023 | $1.60 | 33.33% |
| 2022 | $1.20 | -40.00% |
| 2021 | $2.00 | -39.39% |
| 2020 | $3.30 | 120.00% |
| 2019 | $1.50 | 0.00% |
Utbyttebetalinger for lignende selskaper eller konkurrenter
| Selskap | Antall utbyttebetalinger | Land |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 38.00% |
IN
|
